A diverse response study of Pegylated Somatropin to treat growth hormone deficiency children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017144

Enrollment

Unknown

Registered

2018-07-13

Start date

2018-07-25

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth hormone deficiency

Interventions

Two groups:low dose versus high dose of Pegylated Somatropin

Eligibility

Sex/Gender

All

Age

3 Years to 14 Years

Inclusion criteria

Inclusion criteria: growth hormone deficiency children with Pegylated Somatropin treatment

Exclusion criteria

Exclusion criteria: 1. without medication diary card; 2. without compliance to the protocol.

Design outcomes

Primary

Measure	Time frame
Height standard deviation;	—

Countries

China‘

Contacts

Public ContactJunfen Fu

The Children's Hospital ,Zhejiang University School of Medicine

fjf68@qq.com+86 13777457849

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026